Pure Global

ANTINUCLEAR ANTIBODY (ANA) - ANVISA Registration 10338930305

Access comprehensive regulatory information for ANTINUCLEAR ANTIBODY (ANA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930305 and manufactured by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including INOVA DIAGNOSTICS, INC., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10338930305
Registration Details
ANVISA Registration Number: 10338930305
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IIFT: Crithidia luciliae (anti-dsDNA) EUROPattern
Risk Class II

Registration Details

10338930305

25351840341202366

93741726000166

Company Information

Brazil
PT: BRASIL

Dates and Status

Jan 02, 2024

VIGENTE

09/18/2025 19:00:01